3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
10
Colorectal Neoplasms
8
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
5
Neoplastic Cells, Circulating
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Recurrence
3
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
3
Neoplasm, Residual
3
Disease
3
Squamous Cell Carcinoma of Head and Neck
2
Nevi and Melanomas
2
Neuroendocrine Tumors
2
Nasopharyngeal Carcinoma
2
NSCLC
2
Melanoma
2
Head and Neck Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Smoking
1
Sarcoma, Ewing
1
Interventions
Metformin
7
Surveys and Questionnaires
3
Nutrition Assessment
3
Exercise
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Resistance Training
2
Methods
2
Interviews as Topic
2
Glucose Tolerance Test
2
Educational Status
2
Biopsy
2
tocilizumab
1
tislelizumab
1
pembrolizumab
1
epalrestat
1
donafenib
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Urine Specimen Collection
1
Testosterone
1
Secretin
1
Second Harmonic Generation Microscopy
1
Risk Assessment
1
Remote Consultation
1
Preventive Health Services
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diabetes Mellitus
×
Liquid Biopsy
×
Clear all
NCT06283576
2024-04-24
PANCAID
Karolinska University Hospital
Enrolling by invitation
200 enrolled